• OPEN AN ACCOUNT
Indian Indices
Nifty
22,055.20 97.70
(0.44%)
Sensex
72,664.47 260.30
( 0.36%)
Bank Nifty
47,421.10 -66.80
( -0.14%)
Nifty IT
32,935.15 -270.70
( -0.82%)
Global Indices
Nasdaq
16,346.27 43.51
(0.27%)
Dow Jones
39,387.76 331.37
(0.85%)
Hang Seng
18,963.68 425.87
(2.30%)
Nikkei 225
38,229.11 155.13
(0.41%)
Forex
USD-INR
83.47 0.00
(-0.01%)
EUR-INR
89.79 -0.06
(-0.07%)
GBP-INR
104.34 -0.31
(-0.29%)
JPY-INR
0.54 0.00
(-0.73%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01023
1453.1267897
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
22.59
98073.29
EPS(TTM)
Face Value()
Div & Yield %
260.28
5
0.68
 

dr reddys laboratories ltd
Dr. Reddy's launches condition management programme DailyBloom™ IBS
Apr 19,2024
Dr. Reddy's Laboratories announced the roll-out of its condition management programme DailyBloom™ IBS, India's first integrated care plan for Irritable Bowel Syndrome (IBS). The programme is based on extensive research and is enabled by a mobile application developed in-house. DailyBloom™ IBS focuses on a comprehensive care plan that includes diet management, psychological and physical wellness support for patients with IBS. Dr. Reddy's has launched the programme on ‘World IBS Day', a day that aims to increase awareness of the IBS condition, discuss misconceptions, challenges and even stigma attached to it.